Viral Hepatitis Prevention and Control
Open Opportunities (2)
Live Grants.gov opportunities funded under this program — you can apply now.
- Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP) Deadline: Dec 9, 2026
- National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers Deadline: Jun 1, 2027
See all grants from Centers for Disease Control and Prevention →
Program Funding
Annual program obligations reported to SAM.gov.
Who has received this funding
Organizations awarded under CFDA 93.270 (USAspending.gov).
- National Alliance Of State & Territorial Aids Directors 2 awards $46,360,967
- Colorado Department Of Public Health & Environment $4,584,348
- Research Triangle Institute $4,077,516
- County Of Los Angeles $3,957,368
- Health, Washington State Department Of $3,918,946
- Public Health, Massachusetts Department Of $3,836,735
- Health And Human Resources, West Virginia Department Of $3,760,998
- Florida Department Of Health $3,704,476
- State Of Georgia Department Of Public Health $3,690,257
Program Objective
Program activities support integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. Key strategies include viral hepatitis outbreak planning and response; and surveillance for acute hepatitis A, B and C, and chronic hepatitis C. Partners should develop a jurisdictional viral hepatitis elimination plan, increase comprehensive hepatitis B and C reporting, improve HBV and HCV testing and increase healthcare providers trained to treat hepatitis B and C. Contingent on funding, the following activities can be supported: surveillance for chronic hepatitis B and perinatal hepatitis C; increased hepatitis B and C testing and referral to care in high-impact settings (syringe services programs (SSPs), substance use disorder (SUD) treatment centers, correctional facilities, emergency departments and sexually transmitted disease clinics; and increased access to services preventing viral hepatitis and other infections among persons who inject drugs (PWID). Contingent on funding, an optional component will support improved access to prevention, diagnosis, and treatment of viral, bacterial and fungal infections related to drug use in settings disproportionately affected by drug use. Expected outcomes include improved surveillance for viral hepatitis, increased stakeholder engagement in viral hepatitis elimination planning, and improved access to viral hepatitis prevention, diagnosis, and treatment among populations most at risk.
Eligibility
Eligible Applicants
- U.S. State Government
- U.S. Territory Government
- Federally Recognized Tribal Government
- Tribal Government (other)
- Tribally Designated Housing Authority
- County Government
- Interstate Organization
- Municipality/Township Government
- School District Government
- School District
- Local
- Other Special District Government
- State
- Territorial
- Tribal
- Nonprofit Organization
- For-Profit Organization
Dependent upon the individual NOFO, eligibility may range from open competition, limited competition, single-source, domestic and/or international in accordance with the authorizing legislation.
How to Apply
Award Procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.
Decision Timeline
- Approval: > 180 Days
- Renewal interval: > 180 Days
Program details & compliance
Description
Funds may be used for costs associated with establishing and maintaining a prevention and control program directed towards prevention of viral hepatitis infections and their manifestations. Recipients may only expend funds for reasonable policies, systems and program purposes including personnel, travel, supplies and services, such as reducing transmission of HAV, HBV and HCV, preventing and delaying the progress of chronic infection, as well as educating and training of the general public and health care providers. Recipients may not use funds for clinical care. Recipients may not generally use funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget. The recipient must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award in another party or provider who is eligible.
Mission Categories
Primary: Communicable Diseases
Other categories:
Prevention and Control (includes Suicide Prevention)
Use of Funds
Allowed Uses
Funds may be used for costs associated with establishing and maintaining a prevention and control program directed towards prevention of viral hepatitis infections and their manifestations. Recipients may only expend funds for reasonable policies, systems and program purposes including personnel, travel, supplies and services, such as reducing transmission of HAV, HBV and HCV, preventing and delaying the progress of chronic infection, as well as educating and training of the general public and health care providers.
Required Documentation
Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements